We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 80 start-ups with an aggregate funding of $6.9b. The average funding per company in this subset is $99.3m.
Last update to the database: Feb 18, 2025. See changelog.
Nanomedicine company developing vaccines and therapies with cell-specific targeting.
6
Funding Rounds
$4.6m
Money raised
Scipher Medicine is a precision immunology company that aims to match patients with their most effective therapy. Their proprietary platform, Spectra, combines AI and a network map of protein interactions in the human body to make predictions.
2
Funding Rounds
$192.0m
Money raised
Talus Bioscience is a Seattle-based company founded by Alex Federation.
1
Funding Rounds
$11.2m
Money raised
Translate Bio is a clinical-stage mRNA therapeutics company developing medicines to treat diseases caused by protein or gene dysfunction and vaccines against infectious disease pathogens.
6
Funding Rounds
$227.7m
Money raised
Now known as Sierra Oncology, is a clinical stage drug development company in Vancouver that focuses on cancer and hematology treatments.
2
Funding Rounds
$71.5m
Money raised
Korro Bio is a biotechnology company based in Cambridge, Massachusetts focused on the research and development of RNA editing technology.
2
Funding Rounds
$207.5m
Money raised
Arrakis is developing RNA-targeted small molecule (rSM) therapies to millions of patients.
4
Funding Rounds
$226.0m
Money raised
Spark Therapeutics is a Philadelphia-based therapeutics and biotechnology company founded in 2013.
2
Funding Rounds
$122.8m
Money raised
Quark Pharmaceuticals is a RNAi-based, late stage clinical company founded in 2002 by Daniel Zurr.
1
Funding Rounds
$27.0m
Money raised
Stemirna Therapeutics is an mRNA therapeutics and nanoparticle formulation company in China focused on treatments for cancer, infectious diseases and rare diseases.
1
Funding Rounds
$14.2m
Money raised
DxTerity Diagnostics is a genomics company developing genomic tests for disease diagnosis and monitoring. Los Angeles-based company.
5
Funding Rounds
$4.1m
Money raised
Audentes Therapeutics is a San Francisco-based therapeutics and genetic medicines company.
3
Funding Rounds
$137.5m
Money raised
A therapeutics company developing siRNA and ASO therapeutics that target repeat expansion disorders such as Huntington’s disease, myotonic dystrophy and spinocerebellar ataxias
1
Funding Rounds
$59.0m
Money raised
OyaGen is an HIV Drug Discovery, Editing Enzymes founded in 2003 by Harold Smith.
5
Funding Rounds
$6.6m
Money raised
Seqll is a company providing quantitative RNA and specialty DNA sequencing services.
3
Funding Rounds
$3.0m
Money raised
A research and development company for miRNA-directed treatments for cancer and other diseases
2
Funding Rounds
$36.0m
Money raised
Locanabio is a San Diego, California-based biotechnology company developing RNA-targeting gene therapies.
4
Funding Rounds
$210.6m
Money raised
Spring Bank Pharmaceuticals, Inc. is a company founded in 2002
6
Funding Rounds
$49.6m
Money raised
Small molecule inhibitors of RNA-modifying enzymes for the treatment of cancer
4
Funding Rounds
$101.6m
Money raised
Small Molecules Acting on Stem Cells. Biosplice Therapeutics is in the medical research and development for tissue-level regeneration.
6
Funding Rounds
$799.0m
Money raised
Silence Therapeutics is a London-based company founded in 1999.
1
Funding Rounds
$45.5m
Money raised
Small molecule drugs that target functional 3D RNA structures to treat human diseases.
4
Funding Rounds
$52.8m
Money raised
Eclipse Bioinnovations is a San Diego-based company that develops RNA medicines.
2
Funding Rounds
$29.0m
Money raised
A company that provides cell and tissue based diagnostic tests for personalized medicine development
2
Funding Rounds
$17.4m
Money raised
Strand Therapeutics is a gene Therapy founded by Darrell Irvine, Jacob Becraft, Ron Weiss and Tasuku Kitada.
3
Funding Rounds
$103.1m
Money raised
Expansion Therapeutics is a RNA Targeted Small Molecules founded in 2016.
2
Funding Rounds
$135.3m
Money raised
Geneoscopy, Inc. is a St. Louis-based developer of medical diagnostics systems including non-invasive cancer diagnostics from biomarkers.
4
Funding Rounds
$126.7m
Money raised
Alithea Genomics backgrounds in bioengineering, molecular biology, genomics and lab operations reflect their complementary expertise.
2
Funding Rounds
$2.0m
Money raised
A biotechnology company developing intracellular genetic protein therapy to treat chronic heart failure
3
Funding Rounds
$17.6m
Money raised
Vico Therapeutics is a medicine for rare neurological diseases founded in 2019.
4
Funding Rounds
$179.0m
Money raised
Renova Therapeutics is a company that envisions a future where it can permanently treat chronic diseases
2
Funding Rounds
$7.5m
Money raised
RNAimmune is a biotechnology startup in the field of messenger RNA (mRNA) technology with more than 20 years’ expertise in handling and optimizing this versatile molecule for medical purposes.
3
Funding Rounds
$14.8m
Money raised
Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA) therapeutics.
2
Funding Rounds
$321.0m
Money raised
InteRNA Technologies is a biotech company.
5
Funding Rounds
$37.6m
Money raised
Skyhawk Therapeutics is a RNA-correcting Small Molecules founded in 2016 by Bill Haney.
2
Funding Rounds
$48.0m
Money raised
Mirvie is a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health.Mirvie is a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health.
1
Funding Rounds
$60.0m
Money raised
Abogen Biosciences is a China-based company.
4
Funding Rounds
$1.4b
Money raised
Agilis Biotherapeutics Inc. is a Cambridge, Massachusetts-based biotechnology company founded in 2013.
3
Funding Rounds
$36.3m
Money raised
Small molecule therapies designed to reprogram RNA processing
2
Funding Rounds
$151.0m
Money raised
Twentyeight-Seven is a biomedical startup with a passion for cutting-edge life saving technology.
1
Funding Rounds
$65.0m
Money raised
Amyl Therapeutics unique technology offers a curative solution for all forms of amyloid mediated diseases
3
Funding Rounds
$33.6m
Money raised
Ra Pharmaceuticals is a Cambridge, Massachusetts-based company.
1
Funding Rounds
$8.6m
Money raised
An immunotherapy company developing approaches to enable the body's immune system to fight against diseases
3
Funding Rounds
$99.0m
Money raised
Shape Therapeutics is a RNA-editing gene therapy.
2
Funding Rounds
$147.5m
Money raised
A biotechnology company developing therapies and personalized diagnostics for celiac disease
3
Funding Rounds
$60.0m
Money raised
HDT Bio Corp. is a RNA delivery technology, Immune Activators (Adjuvants.
1
Funding Rounds
$3.0m
Money raised
MiNA Therapeutics is a small activating RNA founded in 2008.
1
Funding Rounds
$23.0m
Money raised
Leyden Labs is a mucosal protection platform founded in 2020.
2
Funding Rounds
$187.1m
Money raised
A company developing biomedical polymers technology for therapeutic applications
2
Funding Rounds
$8.6m
Money raised
A company developing antithrombotic drug systems to treat acute and sub-acute cardiovascular and other indications
3
Funding Rounds
$114.0m
Money raised
A company developing immunomodulators to treat acute inflammatory conditions
2
Funding Rounds
$33.3m
Money raised
GenVec is a biopharmaceutical company developing therapeutics and vaccines founded in 1992.
1
Funding Rounds
$2.0m
Money raised
PhaseRx is a company developing macromolecular therapeutics to treat diseases.
1
Funding Rounds
$19.0m
Money raised
Promosome is a company developing technologies to regulate protein synthesis founded in 2003.
2
Funding Rounds
$13.7m
Money raised
Laronde is a plasmid RNA Therapeutics.
1
Funding Rounds
$440.0m
Money raised
RXi Pharmaceuticals is a company developing ribonucleic acid interference-based therapeutics founded in 2011.
1
Funding Rounds
$23.6m
Money raised
Resalis Therapeutics is developing first-in-class anti-miR compounds to address high unmet medical needs in liver diseases, metabolic disorders, and cancer using a multi-pathway approach.
1
Funding Rounds
$11.0m
Money raised
InDex Pharmaceuticals is a Stockholm-based company developing immunotherapy products.
1
Funding Rounds
$11.3m
Money raised
Cebix is a biopharmaceutical company developing treatments for diabetic complications founded in 2008.
2
Funding Rounds
$46.9m
Money raised
ADARx is developing a RNA targeting platform focused on genetic, cardiometabolic and central nervous system diseases
1
Funding Rounds
$75.0m
Money raised
Abcombi Biosciences is a company founded in 2015 by Andrew Hill, Ph.D. .
1
Funding Rounds
iTolerance is a Miami, Florida-based biotechnology company specializing in regenerative medicine without immunosuppression.
1
Funding Rounds
$20.0m
Money raised
A technology company with a focus on precision oncology solutions.
1
Funding Rounds
$7.0m
Money raised
Wobble Genomics specializes in maximizing RNA and DNA sequencing efficiency for the discovery and detection of nucleic acid biomarkers.
1
Funding Rounds
$11.0m
Money raised
Empowering drug discovery with Proteomics and ML to unlock complex biological insights and enable better therapeutics.
1
Funding Rounds
$8.0m
Money raised
Groove Biopharma. is a biotechnology company.
1
Funding Rounds
$6.0m
Money raised
Codetta Biosciences is a Morrisville, North Carolina-based company.
1
Funding Rounds
$15.0m
Money raised
Quris is an AI Drug Discovery.
1
Funding Rounds
$28.0m
Money raised
Vernal Biosciences is a mRNA Production founded in 2021 by Christian Cobaugh.
1
Funding Rounds
$21.0m
Money raised